Ophthalmological Society of Nigeria
  • About OSN
    • OSN Vision & Mission
    • OSN Officers
    • OSN Committees
    • OSN Zones
    • Contact Us
  • Events & Publications
    • Transactions
    • Nigerian Journal of Ophthalmology
    • Newsletters
    • Annual Congress
    • Upcoming Events
  • Advocacy
    • Global Action Plan
    • OSN Foundation
    • VISION 2020
    • Young Ophthalmologists
  • Subspecialties
    • Anterior Segment and Cornea
    • Glaucoma Society of Nigeria
    • Neuro-ophthalmology
    • Orbit and Oculoplasty
    • Paediatric Ophthalmology
      • “VISION-SAVE” project
      • Nigerian Paediatric Ophthalmology and Strabismus Society
    • Public Health Ophthalmology
    • Vitreoretinal Society of Nigeria
  • Additional Resources
    • CME/Training
      • LSHTM – Eliminating Trachoma
      • CME Providers
      • Other Links
    • Webinar Videos
    • Eye Health
      • Care of the Eye
      • Common Eye Conditions
      • Frequently Asked Questions on Coronavirus
      • First Aid Care
      • Find an Ophthalmologist
    • Careers in Ophthalmology
    • Federal Eye Care Centres
    • State Eye Care Centres
    • Private Eye Clinics
  • Find an Ophthalmologist
  • Download
    • Conference Proceedings
    • Newsletters
    • Videos
    • Others
  • Members
    • Login
    • Create Account
    • OSN Webmail
  •  
  • Home
  • Subspecialties
  • Public Health Ophthalmology

Public Health Ophthalmology

Contact

Dr Ani Olufunmike Patricia
moopani2002@yahoo.com
+2348033264159

Search for:

Basket

Affiliates

Careers in Ophthalmology

Adverts

Ophthalmology News Feed

Stay Up To Date

Ophthalmology Buzz

  • Experimental drug inhibits or prevents diabetic eye disease in new study
    Published: 2023-05-25
  • Experimental drug inhibits or prevents diabetic eye disease
    Published: 2023-05-25
  • AI used to advance drug delivery system for glaucoma and other chronic diseases
    Published: 2023-05-24
  • What Is Causing Progressive Vision Problems in a 32-Year-Old Woman?
    Published: 2023-05-24
  • New Death Tied to Eye Drops; Vax Birds to Prevent Pandemic? Depressed Teens and Guns
    Published: 2023-05-22
  • Study Throws Shade on Cost, Benefits of Laser-Assisted Cataract Surgery
    Published: 2023-05-19
  • One step closer to developing a potentially ultraprotective sunscreen from our own melanin
    Published: 2023-05-18
  • What Caused Visual Disturbance in Kidney Transplant Patient?
    Published: 2023-05-15
  • Foam Bullets Tied to Growing Number of Kids' Eye Injuries
    Published: 2023-05-11
  • New lens analysis approach could improve treatments for nearsightedness
    Published: 2023-05-11
  • Quantum chemistry protects against age-related macular degeneration
    Published: 2023-05-11
  • Exposure to Secondhand Smoke Linked to Myopia in Kids
    Published: 2023-05-11
  • New research sheds light on how human vision perceives scale
    Published: 2023-05-09
  • Implant Matches Topical Timolol for Intraocular Pressure Control, With Good Safety
    Published: 2023-05-09
  • Limited Effect of Laser Treatment on Eye Floaters
    Published: 2023-05-08
  • Artificial Intelligence Creates Inroads to Ophthalmology Clinical Practice
    Published: 2023-05-07
  • Gene responsible for severe facial defects identified
    Published: 2023-05-04
  • Herpes study adds to understanding of viral reinfections, how to potentially prevent them
    Published: 2023-05-01
  • Scientists achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye
    Published: 2023-04-14
  • Refractive error correction among urban and rural school children using two self-adjustable spectacles
    Published: 2023-04-03 By Ocansey, S., Amuda, R., Abraham, C. H., Abu, E. K.
  • Degree of loss in the tissue thickness, microvascular density, specific perimetry and standard perimetry in early glaucoma
    Published: 2023-04-03 By Hirasawa, K., Yamaguchi, J., Nagano, K., Kanno, J., Kasahara, M., Shoji, N.
  • Is the prolongation latency of visual evoked potentials a pathological sign in children with Downs syndrome without ocular abnormalities? Case-control study of children with Downs syndrome
    Published: 2023-03-27 By Utrobicic, D. K., Karlica, H., Jeroncic, A., Borjan, I., Mudnic, I.
  • Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
    Published: 2023-03-22 By Nguyen, Q. D., Moshfeghi, A. A., Lim, J. I., Ponomareva, E., Chauhan, A., Rao, R., Sherman, S.
  • Basal ganglia lesions may be a risk factor for characteristic features of a glaucomatous optic disc: population-based cohort study in Japan
    Published: 2023-03-13 By Fukuoka, H., Nishita, Y., Tange, C., Otsuka, R., Ando, F., Shimokata, H.
  • Refractive error correction among urban and rural school children using two self-adjustable spectacles
    Published: 2023-04-03 By Ocansey, S., Amuda, R., Abraham, C. H., Abu, E. K.
  • Degree of loss in the tissue thickness, microvascular density, specific perimetry and standard perimetry in early glaucoma
    Published: 2023-04-03 By Hirasawa, K., Yamaguchi, J., Nagano, K., Kanno, J., Kasahara, M., Shoji, N.
  • Is the prolongation latency of visual evoked potentials a pathological sign in children with Downs syndrome without ocular abnormalities? Case-control study of children with Downs syndrome
    Published: 2023-03-27 By Utrobicic, D. K., Karlica, H., Jeroncic, A., Borjan, I., Mudnic, I.
  • Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
    Published: 2023-03-22 By Nguyen, Q. D., Moshfeghi, A. A., Lim, J. I., Ponomareva, E., Chauhan, A., Rao, R., Sherman, S.
  • Basal ganglia lesions may be a risk factor for characteristic features of a glaucomatous optic disc: population-based cohort study in Japan
    Published: 2023-03-13 By Fukuoka, H., Nishita, Y., Tange, C., Otsuka, R., Ando, F., Shimokata, H.

Social

  • Twitter
  • Facebook
  • LinkedIn
  • Youtube

c/o Ophthalmology Department
University College Hospital (UCH)
P. O. Box 29589, Secretariat
Ibadan, Nigeria

osn.national@gmail.com
+234 802 389 0063
+234 806 769 8560

Medical Disclaimer
Our Affiliates
Privacy Statement

For Advertisers

Copyright © All rights reserved.
Design by HYPERTERMINAL Solutions